Skip to content

Drug interactions

Eliglustat + Topotecan

Severity: Moderate

Eliglustat and Topotecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eliglustat inhibits P-glycoprotein, and topotecan is a P-gp and BCRP substrate. Higher topotecan exposure is possible, which may worsen neutropenia and other toxicities.

What this interaction means in plain words

Eliglustat and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eliglustat belongs to Miscellaneous; Topotecan belongs to Oncology.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by eliglustat reduces efflux and clearance of topotecan.

What to do

Monitor complete blood counts closely and reduce the topotecan dose if marked myelosuppression occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Topotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Topotecan?

MediHelp rates the interaction as moderate. Eliglustat and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eliglustat inhibits P-glycoprotein, and topotecan is a P-gp and BCRP substrate. Higher topotecan exposure is possible, which may worsen neutropenia and other toxicities.

How serious is the interaction between Eliglustat and Topotecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts closely and reduce the topotecan dose if marked myelosuppression occurs.

What other medicines interact with Topotecan?

MediHelp also lists interactions of Topotecan with, for example, Adenovirus types 4 and 7 live, Amiodarone, Cisplatin. The full list is on the Topotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in